You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mig6 Expression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia, Adult
    • Freiburg, CA, Germany
      Medical Center- University of Freiburg
    Aug 4, 2023

    Acne Vulgaris, Vitamin D Trial in Jakarta Pusat (combination oral and topical vitamin D, oral and topical cholecalciferol, oral

    Enrolling by invitation
    • Acne Vulgaris
    • Vitamin D
    • combination oral and topical vitamin D
    • +2 more
    • Jakarta Pusat, DKI Jakarta, Indonesia
      RSUPN Dr. Cipto Mangunkusumo
    Mar 4, 2023

    Klotho _ LRP-6 _ Gastric Adenocarcinoma

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Prognostic study
    • (no location specified)
    Jan 29, 2023

    Breast Cancer, Female Trial in Tomsk (ADAPT6-SPECT)

    Recruiting
    • Breast Cancer
    • Female
    • Tomsk, Russian Federation
      Tomsk NRMC
    Jun 7, 2022

    Amyotrophic Lateral Sclerosis Trial in St. Gallen ([18F]-RoSMA-18-d6)

    Not yet recruiting
    • Amyotrophic Lateral Sclerosis
    • St. Gallen, Switzerland
      Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen
    May 19, 2023

    Gene Expression Profiles in Spinal Tuberculosis.

    Recruiting
    • Tuberculosis, Spinal
    • +13 more
      • Cape Town, Western Cape, South Africa
        Groote Schuur Hospital
      Nov 7, 2022

      Rheumatoid Arthritis Trial in Los Angeles, Chicago, London (Tc 99m tilmanocept)

      Recruiting
      • Rheumatoid Arthritis
      • Tc 99m tilmanocept
      • Los Angeles, California
      • +3 more
      Sep 13, 2022

      Solid Tumors, Adult Trial in Dallas, Hangzhou (HF158K1 /Arm 2 mg/m², HF158K1 /Arm 6 mg/m², HF158K1 /Arm 15 mg/m²)

      Not yet recruiting
      • Solid Tumors, Adult
      • HF158K1 /Arm 2 mg/m²
      • +5 more
      • Dallas, Texas
      • +2 more
      May 6, 2023

      DetectIon of Severe Sepsis In PATients With Neurological

      Recruiting
      • Sepsis
      • Hemorrhage Brain
      • APTT CWA (Activated partial thromboplastin time clot waveform analysis), Procalcitonin and Serological/Inflammatory markers (KL-6, SPA, MIG, Presepsin)
      • Singapore, Singapore
        National University Hospital, Singapore
      Jan 4, 2022

      Breast Cancer Female Trial in Tomsk (99mTc-ADAPT6, 99mTc-DARPinG3)

      Recruiting
      • Breast Cancer Female
      • Tomsk, Russian Federation
        Tomsk NRMC
      May 12, 2022

      Cancer, Malignant Tumor Trial in Chapel Hill (Bioelectrical impedance Analysis (BIA), D3-Creatine Dilution (D3Cr), 6-Minute Walk

      Not yet recruiting
      • Cancer
      • Malignant Neoplasm
      • Bioelectrical impedance Analysis (BIA)
      • +7 more
      • Chapel Hill, North Carolina
        UNC Lineberger Comprehensive Cancer Center
      Apr 10, 2023

      Waldenström Macroglobulinemia Trial in Vandoeuvre les Nancy (Blood or bone marrow samples)

      Completed
      • Waldenström Macroglobulinemia
      • Blood or bone marrow samples
      • Vandoeuvre les Nancy, France
        CHRU Nancy
      Aug 1, 2021

      Type2 Diabetes Trial in Jakarta (Vitamin D 5000 IU, Placebo)

      Active, not recruiting
      • Type2 Diabetes Mellitus
      • Vitamin D 5000 IU
      • Placebo
      • Jakarta, DKI Jakarta, Indonesia
        Community Health Centers Kecamatan Mampang Prapatan
      Oct 24, 2022

      Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

      Not yet recruiting
      • Newly Diagnosed Multiple Myeloma
      • Hamburg, Germany
      • +3 more
      Dec 16, 2022

      O6-methylguanine-DNA Methyltransferase Promoter Methylation and

      Active, not recruiting
      • Sarcoma
      • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
      • Naples, Campania, Italy
        National Cancer Institute of Naples
      May 14, 2021

      Retinitis Pigmentosa Trial in Nantes (AAV2/5-hPDE6B)

      Active, not recruiting
      • Retinitis Pigmentosa
      • AAV2/5-hPDE6B
      • Nantes, France
        Clinique Ophtalmologique, CHU de Nantes
      Feb 28, 2022

      Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)

      Active, not recruiting
      • Breast Cancer
      • Breast Neoplasm
      • Philadelphia, Pennsylvania
        University of Pennsylvania Hospital
      Jan 17, 2023

      miR-155 Expression in Episodic and Chronic Migraine

      Recruiting
      • Migraine
      • +3 more
        • Pavia, Italy
          IRCCS Mondino Foundation
        Jun 7, 2023

        Gold Nanoparticles in Salivary Gland Tumours

        Completed
        • Carcinoma Ex Pleomorphic Adenoma of Salivary Glands
        • Pleomorphic Adenoma of Salivary Glands
        • CD24-Gold Nanocomposite expression using Real-time quantitative polymerase chain reaction
        • non-conjugated CD24 expression using Real-time quantitative polymerase chain reaction
        • Giza, Egypt
          Faculty of Dentistry, October 6 University
        Aug 31, 2021

        Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in

        Recruiting
        • DCIS
          • Victoria, British Columbia, Canada
          • +9 more
          Jan 31, 2023

          Resectable Pancreatic Cancer Trial in Canada (Modified Folforinox (mFFX))

          Recruiting
          • Resectable Pancreatic Cancer
          • Modified Folforinox (mFFX)
          • Vancouver, British Columbia, Canada
          • +7 more
          Jun 24, 2021

          Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

          Recruiting
          • Advanced Solid Tumor Historically Known for High EphA2 Expression
          • +6 more
          • Encinitas, California
          • +27 more
          Aug 17, 2022

          Type I IFN Level and Disease Activity in SLE Patients

          Not yet recruiting
          • Elevated Level of IFN Type I in SLE Patients
          • study of IFNGS expression biomarkers
          • (no location specified)
          Jun 30, 2022

          Healthy Subject, Intracranial Tumor, Glioblastoma Trial in Palo Alto (Fluorine F 18 DASA-23, Positron Emission Tomography)

          Recruiting
          • Healthy Subject
          • +2 more
          • Fluorine F 18 DASA-23
          • Positron Emission Tomography
          • Palo Alto, California
            Stanford University, School of Medicine
          Sep 2, 2021

          COPD Trial in Vancouver (Prednisone)

          Active, not recruiting
          • Chronic Obstructive Pulmonary Disease
          • Vancouver, British Columbia, Canada
            St. Paul's Hospital
          Apr 28, 2021